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Listeriawas first described in 1926 byMurray,Webb, and Swann, who discovered it while investigating an epidemic infection among
laboratory rabbits and guinea pigs. The role of Listeria monocytogenes as a foodborne pathogen was definitively recognized during
the 1980s.This recognitionwas the consequence of a number of epidemic humanoutbreaks due to the consumption of contaminated
foods, in Canada, in the USA and in Europe. Listeriosis is especially severe in immunocompromised individuals such as pregnant
women. The disease has a low incidence of infection, although this is undeniably increasing, with a high fatality rate amongst
those infected. In pregnant women listeriosis may cause abortion, fetal death, or neonatal morbidity in the form of septicemia
and meningitis. Improved education concerning the disease, its transmission, and prevention measures for immunocompromised
individuals and pregnant women has been identified as a pressing need.
1. Introduction
Listeria monocytogenes is a Gram positive, facultative intra-
cellular, foodborne pathogen responsible for cases and out-
breaks of listeriosis. Listeria was first described in 1926
by Murray et al. who discovered it while investigating an
epidemic infection among laboratory rabbits and guinea pigs
[1]. At that time, it was given the name Bacterium monocyto-
genes because infection in the animals was characterized by
monocytosis. The following year, Pirie isolated an identical
bacterium from the liver of several gerbils and proposed
the name Listerella for the genus in honor of Lord Lister a
prominent surgeon of the time [2]. Despite considerable con-
fusion in the nomenclature of the pathogen until 1940, the
official name Listeria monocytogeneswas adopted in the Sixth
Edition of Bergey’s Manual of Determinative Bacteriology
[3].
The first cases of human listeriosis were reported by
Nyfeldt in 1929 [4]. The increased number of reported cases
during the 1980s in several countries, and the evidence of
foodborne transmission, turned listeriosis into a recognized
foodborne disease [5, 6]. Listeriosis has emerged as an atypi-
cal foodborne illness of major public health concern because
of the severity of the disease (meningitis, septicemia, and
abortion), the high case fatality rate (20–30% of cases), the
long incubation period, and the predilection for individuals
who have an underlying conditionwhich leads to impairment
of T-cell-mediated immunity [7]. In addition, the ubiquitous
nature of L. monocytogenes and its ability to survive and grow
in harsh conditions (wide pH range, high salt concentration,
refrigeration temperatures) makes this pathogen of high
concern to the food industry.
It has been reported that the annual incidence of liste-
riosis ranges between 1 and 10 per million population [8].
Although listeriosis is less common than other foodborne
diseases, 19% and 17% of the known causes of foodborne
disease-related deaths occurring in the USA and France,
respectively, are caused by L. monocytogenes [9, 10].
Most authors comment that 99% of the human Listeria
infections are from foodborne origin [11–14]. Listeria mono-
cytogenes has been recovered from several foods such as
meat, milk, and fish products; ice cream; vegetables; and
several ready-to-eat foods [15–17]. There are recent surveys
of L. monocytogenes in foods that demonstrate the presence
of this bacterium in several of these foods and ready-to-eat
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products [12, 17–23]. Also, there have been several listeriosis
outbreaks worldwide [24–28], and certain foods have been
described as “high risk” for listeriosis. In recent years the
annual number of reported listeriosis cases has increased in
several European countries [29–33]. Goulet et al. [30] and
Shetty et al. [6] suggest that this increase is particularly due
to the increasing population aged more than 60 years, or
less than 60 years, although with an immunocompromised
predisposing condition.
Listeria monocytogenes is responsible for cases and out-
breaks of febrile gastrointestinal disease in otherwise healthy
people and invasive listeriosis, which more usually affects
pregnant, newborns, the elderly, and immunecompromised
individuals. According to Warriner and Namvar [25] non-
invasive listeriosis is associated with a huge intake of L.
monocytogenes.
Listeria monocytogenes has been differentiated into 13
serotypes; serotypes 1/2a, 1/2b, and 4b have been involved in
the majority of reported human listeriosis cases [33].
Subtype characterization of L. monocytogenes isolates
from listeriosis outbreaks has suggested that many outbreaks
were caused by a small number of L. monocytogenes epi-
demic clones [34], that is, by a closely related group of isolates
that evolved clonally. Epidemic clones of L. monocytogenes
have been implicated in several outbreaks and sporadic cases
of listeriosis worldwide [35–37], and for this reason, although
not yet proven, they have been consideredmore virulent than
other strains.
2. High Risk Foods for Listeria Infection
High-risk foods have all of the following properties: (1) have
the potential for contamination with L. monocytogenes (2)
support the growth of L. monocytogenes to high numbers,
(3) do not require further cooking at home (4) require
refrigeration, (5) have an extended shelf life, and (6) are
contaminated with high levels of the pathogen at the time
of consumption [13, 38, 39]. Ready-to-eat seafood such as
smoked fish or mussels, raw seafood including sushi and
sashimi, premixed raw vegetables including coleslaw, meat
products such as sausages, paté, and rillettes, hot dogs, ham,
salami, chicken wraps and deli turkey breast, unpasteurized
milk, soft-serve ice creams, and soft cheeses are examples
of foods that have been associated with transmission of
listeriosis.
The minimum number of cells capable of causing disease
is not known although epidemiological data suggest that it is
high (ca. 106 CFU/g) [40]; the infectious dose depends on the
strain virulence and the host susceptibility [40, 41].
The characteristics of the disease (the hugely variable
and potentially very long incubation periods, the low attack
rates, and the rarity of identification of specific food vehicles),
provide limited data for calculation of dose responses [42].
3. Mechanisms of Infection
Listeria monocytogenes has the ability to induce its own entry
into host cells, usually mammalian cells (human and animal),
such as macrophages, epithelial cells, and endothelial cells
of the gastrointestinal tract [43]. After ingestion, those cells
surviving the low pH in the stomach pass through to
the small intestine—the first site where invasion occurs—
disseminate from the mesenteric lymph nodes to the spleen
and the liver and from there L. monocytogenes can reach the
brain or the placenta [44], causing, respectively, infections
of the central nervous system (CNS) mostly in immuno-
compromised patients and intrauterine/cervical infections in
pregnant women [40].
Listeria monocytogenes uses various proteins, including
some internalins to adhere and to invade the host cells.
Once in the intracellular phagocytic vacuole, bacteria secrete
listeriolysins and phospholipases that allow it to lyse the
vacuolar membrane and avoid intracellular killing. Upon
being released into the cytoplasm, L. monocytogenes can
multiply and induce the formation of actin filaments which
will allow it to move in the cytoplasm until it reaches the
plasma membrane. Subsequently, adjacent cells are inva-
ded through plasma membrane protrusions and cell-to-cell
spread. Through this cycle L. monocytogenes can move from
one host cell to another cell, without being in the extracellular
environment, thus escaping from the human T-cell immune
system, and invading other tissues and organs [45, 46].
4. Incubation Period for Listeriosis
Unlike other foodborne diseases, the incubation period for
listeriosis can be long. Goulet et al. [47] recently reported
an overall median incubation period of invasive listeriosis
of 8 days, ranging from 1 to 67 days. For pregnancy-
associated cases the authors reported a longer incubation
period (median 27.5 days, ranging from 17 to 67 days) than for
CNS cases (median 9 days, ranging from 1 to 14 days) and for
bacteraemia cases (median 2 days, ranging 1 to 12 days). For
febrile gastrointestinal disease, themedian incubation period
was reported as 24 hours, ranging from 6 hours to 10 days
[47].
5. Individuals at Higher Risk of Listeriosis
Although exposure and colonization may occur in any
person, those patients without predisposing factors represent
less than 20% of the cases [48]. Silk et al. [49] reported
an incidence rate of listeriosis of 0.27 cases per 100,000
general US population.There are well-defined risk groups for
human invasive listeriosis: pregnant women and their fetuses
or neonates, the elderly, and cellular immunocompromised
individuals such as those who are receiving corticosteroids
or chemotherapy, hemodialysis, transplants, diabetic, HIV
carriers, and drug dependents [40, 50]. Ogunmodede et al.
[51] found that pregnant women have an infection risk twenty
times higher than other healthy adults. Incidence rates among
pregnant women and adults aged more than 65 years were
reported in the USA as 3.42 and 1.21 cases per 100,000
population, respectively [49]. Pregnant Hispanic women are
also recognized as having a much higher infection risk than
pregnant women of other ethnicities [52, 53], probably due
to the habit of the consuming soft cheese [13, 54]. In a
recent study by Pouillot et al. [53] it was demonstrated
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that a significant increase in listeriosis incidence begins
among persons as young as 45 years and that incidence rates
subsequently increase steadily with age.
6. Invasive Listeriosis
In adults, the most common clinical form of listeriosis is
meningitis, due to the bacterial tropism to the central nervous
system [44, 55]. Salamano et al. [54] reported that meningitis
caused by Listeria represents 5% to 11% of all acute bacterial
meningitis in adults, reaching 14% in patients agedmore than
45 years. Apparently, individuals with predisposing factors
seem to suffer more from septicemia rather than meningitis,
but this situation may be due to the followup of these
individuals by the health system,making themmore available
for blood collection and culture in the case of a febrile
episode [41]. A survey of 782 listeriosis cases reported in 20
countries, showed that 43% of the infections were related
with pregnancy, 29% with septicemia, 24% with central
nervous system infection, and 4% were atypical forms of the
infection [56]. Listeria infections may produce sequelae, but
the incidence is rarely determined. Up to 11% of neonates
and 30% of patients that survive central nervous system
infections, suffer from residual symptoms and psychiatric
sequelae [52, 56, 57]. Salamano et al. [54] reported a high level
of recurrences (7%).
6.1. Listeriosis during Pregnancy. During pregnancy, cellular
immunity is minimal due to the increased progesterone
[58, 59], making pregnant women particularly susceptible
to intracellular microorganisms like L. monocytogenes [51,
60]. The vertical cell-to-cell transmission is frequent since
L. monocytogenes shows uterus and placenta tropism [48,
51]. Immunological aspects of Listeria infection during preg-
nancy were reviewed by Poulsen and Czuprynski [61].
Goulet et al. [30] reported that the incidence in pregnant
women and neonates appears to be decreasing in Europe.
On the contrary Sisó et al. [62] reported an increase in
the incidence of listeriosis between 2000 and 2010 in a
tertiary referral hospital in Barcelona. It is important to
point out that listeriosis is not often diagnosed in pregnancy,
due to the microbiological diagnostic techniques being dif-
ficult, and also due to the histological alterations in the
placenta being similar to other diseases, hindering, therefore,
a definitive assessment of the importance of listeriosis in
pregnancy health [63]. Moreover, pregnant women may be
asymptomatic or present nonspecific clinical symptoms (e.g.,
flu-like symptoms, backache, headache, vomiting/diarrhea,
muscle pains, and sore throat) [64–66]. Gupta et al. [67]
stated that microbiological examinations are not usually
made on spontaneous or premature abortions; thus, it is
difficult to infer the actual incidence of listeriosis [68].
Infection by L. monocytogenes during pregnancy may
result in serious outcomes including miscarriage, stillbirth,
chorioamnionitis, pretermdelivery, andmaternal and neona-
tal sepsis [65, 66].
It is agreed that there is an increased susceptibility
for listeriosis in late pregnancy. A third of the listeriosis
cases affect pregnant women mostly in the third trimester
of pregnancy [48, 58, 59], rarely in the second and only
exceptionally occurs in the first trimester [63]. Studies by
Sisó et al. [62] reported an incidence of the infection two
times higher after 28 weeks of gestation than in the first
trimesters. Listeriosis during early gestations generally has a
poorer prognosis for fetuses as opposed to later gestations
and commonly results in miscarriage or stillbirth [62, 65, 67].
DiMaio [48] commented that iron supplement, commonly
prescribed during pregnancy, favors the development of
listeriosis.
A transplacentary fetal infection may result in abortion,
as already stated, premature birth, or an infected neonate [54,
68]. Laciar et al. [68] Doyle [58] and Schwab and Edelweiss
[69] agree that most cases of the intrauterine infection are
a consequence of the transplacentary dissemination after
bacteremia in pregnant women and less frequently due to
an ascending contamination from the pregnant woman’s
lower genital tract colonized by L. monocytogenes, as the
vagina and cervix are also potentially carrier sites of this
microorganism [48]. More commonly, infection during the
passage of the fetus through the birth canal may result in the
nosocomial transmission in the neonatal nursery [70]. Two
distinct infection forms are described in the newborns.
6.1.1. Early-Onset Neonatal Listeriosis. This is acquired in
utero, by transplacentary transmission, and is also known as
granulomatosis infantiseptica. Disease in pregnancy precedes
the fetal infection, although symptoms may not be specific
[48, 70]. This infection, generally occurring at a mean of
36 h after birth [71], and probably due to aspiration of
infected amniotic liquid, is characterized by clinical features
like septicemia (81–88%), respiratory distress or pneumonia
(38%), and meningitis (24%) [72, 73].The formation and dis-
semination of abscesses and granulomas in multiple organs
may occur [55]. The mortality rate for infants born alive
approaches 20%, and the frequency of abortion and stillbirth
increases the overall mortality rate to more than 50% [74].
6.1.2. Late-Onset Neonatal Listeriosis. Infection occurs par-
ticularly during delivery, by contamination, with symptoms
such as meningitis or meningoencephalitis together with
septicemia, occurring 2 or 3weeks after delivery [70]. In these
cases deliveries are not complicated and the transmission
may be in the passage through the birth canal; the more
frequent occurrence during deliveries by caesarean section
being relevant, suggesting nosocomial transmission [48, 52].
The mortality rate associated with late-onset disease is
ca. 10% [69], but as commented by DeWaal et al. [75] and
Buzby [76] a high rate of surviving babies develop severe
and chronic neurological complications, for example, delayed
mental development and blindness.
6.2. Diagnosis of Listeriosis. The diagnosis of listeriosis
depends upon detecting the growth of themicroorganisms in
corporal fluids normally considered as sterile-blood, amni-
otic, and cerebrospinal fluids [48, 57]. A rapid diagnosis
would be important for preventing recurrences in pregnan-
cies and to treat neonatal infections that may cause menin-
gitis with sequelae such as hydrocephaly, delayed mental
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development, convulsions, and other neurological symptoms
[58, 75, 76].
The diagnosis of listeriosis in pregnancy and early treat-
ment would be possible if all the febrile episodes during
pregnancy were evaluated through a blood culture [67, 68].
For this purpose, pregnant women should report any disease
symptom, because listeriosis can be apparently harmless for
the pregnant woman but severely infect the fetus [52, 75, 77].
6.3. Treatment of Listeriosis. Listeriosis often requires anti-
microbial therapy. The treatment of choice consists of a 𝛽-
lactam antibiotic, normally ampicillin, alone or in combina-
tion with an aminoglycoside, classically gentamicin. Second-
line agents in case of allergy to 𝛽-lactams or in cert-
ain disease states include trimethoprim/sulfamethoxazole,
erythromycin, vancomycin, and the fluoroquinolones [78].
Resistance of clinical isolates of L. monocytogenes to these
antibiotics is low [79]. Early diagnosis and antibiotic admin-
istration increases the probability of a favorable outcome
[62, 78].
7. How to Reduce the Incidence of Listeriosis
Due to the high mortality rate of listeriosis, it is necessary to
reduce its incidence. For that purpose, it is urgent to identify
the most efficacious strategies based on risk assessment from
food production to consumption [13, 48].
According to the International Life Sciences Institute [13],
the use of scientifically-based messages, to high-risk groups
and in health professionals, education is one of the main
strategies to adopt concerning the reduction of listeriosis
incidence, because it is generally accepted that in some
foods, L. monocytogenes absence may not be possible. These
strategies should minimize food contamination and educate
the population in general and risk groups in particular,
as well as health professionals and care providers [13, 41].
Cates et al. [80] concluded from their study about listeriosis
information transmission to pregnant women that if we want
the message to be well delivered to those at risk, it should
be targeted and appealing to the pregnant woman; provide
detailed information about sources, prevention measures,
morbidity, andmortality rates (but as simple as “1 in 4”, rather
than 25%); give emphasis to words like “abortion”, “premature
birth”; and be transmitted by the obstetrician or other doctor.
“Preventative” public alerts about concerning listeriosis





.us/divs/idepc/diseases/listeriosis/index.html). Wong et al.
[81] commented that in the USA, doctors are considered by
the population as the most credible source of information
about health. Doctors are important food safety educators
as during the year, they are in contact with 80% of the
population, and also because people are more likely to
change behaviors if they have been recently ill. Hence,
campaigns about food safety education targeted for doctors
are recommended [81], especially for obstetricians, as
pregnant women will not change their attitudes if they do
not recognize the source of the information or if they do not
believe it [82].
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